2022
DOI: 10.1111/jpi.12787
|View full text |Cite
|
Sign up to set email alerts
|

Activation of melatonin receptor 1 by CRISPR‐Cas9 activator ameliorates cognitive deficits in an Alzheimer's disease mouse model

Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the presence of neurotoxic beta-amyloid (Aβ) in the brain.Melatonin receptors have been reported to associate with aging and AD, and their expression decreased with the progression of AD. As an alternative to AD treatment, overexpression of melatonin receptors may lead to melatonin-like effects to treat alleviate the symptoms of AD. Here, we successfully activated the type 1 melatonin receptor (Mt1) in vivo brain using a Cas9… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 69 publications
0
8
0
Order By: Relevance
“…p-values <0.05 were considered statistically significant (*p < 0.05 and **p < 0.01). No statistical methods were used to pre-determine sample sizes; however, our sample sizes were similar to those reported in previous publications [49][50][51][52][53][54][55][56] . Data collection and analysis were randomized and blinded.…”
Section: Discussionmentioning
confidence: 66%
“…p-values <0.05 were considered statistically significant (*p < 0.05 and **p < 0.01). No statistical methods were used to pre-determine sample sizes; however, our sample sizes were similar to those reported in previous publications [49][50][51][52][53][54][55][56] . Data collection and analysis were randomized and blinded.…”
Section: Discussionmentioning
confidence: 66%
“…Animal experiments showed that melatonin can inhibit expressions of amyloid-β protein in the hippocampal area of model rats with senile dementia [ 44 ]. Activation of the type 1 melatonin receptor modulated anti-amyloidogenic and anti-inflammatory roles in AD mice brain and improved the cognitive deficits [ 45 ]. Shift work was also associated with abnormalities in brain structure that had been observed in dementia pathophysiology, giving a hint of the underlying brain mechanisms of shift work on dementia risk [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…24,25 Melatonin is a potent free radical scavenger that has demonstrated beneficial effects in animal models of acute injuries, such as spinal cord injury (SCI), and chronic injuries, such as Parkinson's disease related to the CNS. [26][27][28][29][30] As a chronic nontraumatic SCI, we inferred that melatonin may be effective in treating CSM. In this in vivo experiment, we aimed to evaluate whether melatonin inhibited neuronal apoptosis by restoring ER homeostasis, alleviating ER stress, and promoting ERphagy, ultimately improving neurological function in a rat model of chronic cervical cord compression.…”
Section: Introductionmentioning
confidence: 95%
“…Melatonin is a potent free radical scavenger that has demonstrated beneficial effects in animal models of acute injuries, such as spinal cord injury (SCI), and chronic injuries, such as Parkinson's disease related to the CNS 26–30 . As a chronic nontraumatic SCI, we inferred that melatonin may be effective in treating CSM.…”
Section: Introductionmentioning
confidence: 99%